Dr. Anna La Salvia is a medical oncologist with a particular interest in the field of neuroendocrine tumors. She has attained her PhD at Complutense University of Madrid, Spain, and she has worked at the Gastrointestinal and Neuroendocrine Tumor Unit, University Hospital 12 de Octubre, Madrid, Spain (2019–2021) and at the Medical Oncology Unit 2, Clinical Department and Oncological Research, Regina Elena National Cancer Institute (IRCCS) (January–October 2022). Currently, she is a Researcher for the National Center for Drug Research and Evaluation, at the National Institute of Health (ISS). She has been involved as a sub-investigators in many phase I-II-III clinical trials, as well as numerous translational research projects. Her scientific work Is focused on translational research and clinical Oncology, and it is mainly focused on neuroendocrine tumors.
Istituto Superiore di Sanità
Rome, Lazio, Italy
FARVA